Literature DB >> 15837729

The clinical relevance of steroid hormone receptor corepressors.

Rakesh Kumar1, Anupama E Gururaj, Ratna K Vadlamudi, Suresh K Rayala.   

Abstract

Steroid hormone receptors are ligand-dependent transcription factors that control a variety of essential physiologic and developmental processes in humans. The functional activity of a steroid receptor is regulated not only by hormones but also by an array of regulatory proteins such as coactivators, corepressors, and chromatin modifiers. Contrary to an earlier notion that corepressors and coactivators exist in separate complexes, these molecules, which have apparently opposite functions, are increasingly being found in the same complex, which allows for efficient transcriptional control mechanisms. These control mechanisms are in turn regulated by an array of post-translational modifications under the influence of upstream and local signaling networks. Because the outcome of steroidal hormone receptor transcriptional complexes is measured in terms of the expression of target genes, any dysregulation of coregulator complexes perturbs normal homeostasis and could contribute to the development and maintenance of malignant phenotypes. Increasing evidence implicating steroid hormone receptors and their coregulators in various pathophysiologic conditions has elicited interest in their structure and biology. Further advances in this field of study should open up a unique window for novel targeted therapies for diseases such as cancer. Here we briefly review the clinical relevance of corepressors, with a particular focus on their role in the development of cancerous phenotypes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15837729     DOI: 10.1158/1078-0432.CCR-04-1276

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  16 in total

Review 1.  MTA family of transcriptional metaregulators in mammary gland morphogenesis and breast cancer.

Authors:  Rajesh R Singh; Rakesh Kumar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2007-09       Impact factor: 2.673

Review 2.  Regulation of hormone signaling by nuclear receptor interacting proteins.

Authors:  Vanessa Duong; Patrick Augereau; Eric Badia; Stéphan Jalaguier; Vincent Cavailles
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 3.  Minireview: Deciphering the Cellular Functions of PELP1.

Authors:  Preethi Ravindranathan; Carol A Lange; Ganesh V Raj
Journal:  Mol Endocrinol       Date:  2015-07-09

Review 4.  Transcriptional co-repressors and memory storage.

Authors:  Hannah Schoch; Ted Abel
Journal:  Neuropharmacology       Date:  2014-01-17       Impact factor: 5.250

5.  MTA1, a transcriptional activator of breast cancer amplified sequence 3.

Authors:  Anupama E Gururaj; Rajesh R Singh; Suresh K Rayala; Caroline Holm; Petra den Hollander; Hao Zhang; Seetharaman Balasenthil; Amjad H Talukder; Goran Landberg; Rakesh Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-14       Impact factor: 11.205

Review 6.  Pathways to tamoxifen resistance.

Authors:  Rebecca B Riggins; Randy S Schrecengost; Michael S Guerrero; Amy H Bouton
Journal:  Cancer Lett       Date:  2007-05-01       Impact factor: 8.679

7.  Stable differentiation and clonality of murine long-term hematopoiesis after extended reduced-intensity selection for MGMT P140K transgene expression.

Authors:  Claudia R Ball; Ingo H Pilz; Manfred Schmidt; Sylvia Fessler; David A Williams; Christof von Kalle; Hanno Glimm
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

8.  Acid ceramidase (ASAH1) represses steroidogenic factor 1-dependent gene transcription in H295R human adrenocortical cells by binding to the receptor.

Authors:  Natasha C Lucki; Donghui Li; Sibali Bandyopadhyay; Elaine Wang; Alfred H Merrill; Marion B Sewer
Journal:  Mol Cell Biol       Date:  2012-08-27       Impact factor: 4.272

9.  Augmentation of estrogen receptor-mediated transcription by steroid and xenobiotic receptor.

Authors:  Nana Rokutanda; Toshiharu Iwasaki; Hiroki Odawara; Rin Nagaoka; Wataru Miyazaki; Akira Takeshita; Yukio Koibuchi; Jun Horiguchi; Noriaki Shimokawa; Yuichi Iino; Yasuo Morishita; Noriyuki Koibuchi
Journal:  Endocrine       Date:  2008-06       Impact factor: 3.633

10.  RAC3 is a pro-migratory co-activator of ERα.

Authors:  M P Walker; M Zhang; T P Le; P Wu; M Lainé; G L Greene
Journal:  Oncogene       Date:  2011-01-10       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.